GLP-1 Medications vs Testosterone Therapy for Weight Loss in Men: What Actually Works

Michael, a 48-year-old accountant, sat in his doctor's office with a familiar complaint. Despite eating less and exercising more, he'd gained 30 pounds over five years. His energy was low, his waistline kept expanding, and he'd read online that testosterone therapy might be the answer. "Could low testosterone be causing my weight gain?" he asked. His doctor ordered bloodwork, which showed his testosterone was actually in the normal range — but his A1C was trending toward prediabetes. This scenario plays out in clinics across the country every day, and it highlights a critical question many men face: should they pursue testosterone therapy or GLP-1 medications for weight loss?

The answer isn't always straightforward. Both testosterone replacement therapy (TRT) and GLP-1 receptor agonists like Semaglutide and Tirzepatide can affect body composition, but they work through entirely different mechanisms and are appropriate for very different situations. Let's break down what each therapy actually does, who benefits most, and what the clinical evidence really shows.

How Testosterone Therapy Affects Weight and Metabolism

Testosterone replacement therapy was never primarily designed as a weight loss treatment. It's a hormone replacement strategy for men with clinically diagnosed hypogonadism — a condition where the body doesn't produce adequate testosterone levels. True hypogonadism affects only about 2-4% of men, though you wouldn't know it from the marketing of testosterone clinics that have proliferated in recent years.

When testosterone levels are genuinely low (typically below 300 ng/dL on multiple morning blood tests), replacement therapy can lead to modest improvements in body composition. Men with hypogonadism who start TRT often see an increase in lean muscle mass and a decrease in fat mass over time. A large meta-analysis published in 2016 found that men with low testosterone who received replacement therapy lost an average of about 2-3 kg (4-7 pounds) over 6-12 months compared to placebo. That's not nothing, but it's also not the dramatic transformation many men hope for.

Here's what actually happens physiologically: testosterone influences where your body stores fat and how efficiently it builds muscle. When levels are low, men tend to accumulate more visceral fat — the dangerous kind around organs — and have a harder time maintaining muscle mass. Restoring testosterone to normal levels can shift this balance somewhat. You'll likely find it easier to build muscle when you lift weights, and you may notice modest reductions in body fat, particularly around the midsection.

But there's a catch that's rarely discussed in men's health forums. If your testosterone is already in the normal range (roughly 300-1000 ng/dL), taking additional testosterone won't accelerate weight loss. In fact, it can be counterproductive and potentially dangerous. We see this frequently in our patients who come to us after trying TRT elsewhere — they were prescribed testosterone despite having normal levels, experienced minimal weight loss, and now face the complications of unnecessary hormone therapy.

How GLP-1 Medications Work for Weight Loss

GLP-1 receptor agonists operate through an entirely different mechanism that directly targets the biological systems controlling appetite and food intake. These medications — which include Semaglutide (the active ingredient in Wegovy) and Tirzepatide (Mounjaro/Zepbound) — mimic a natural hormone your gut produces after eating.

When you take a GLP-1 medication, several things happen simultaneously. The drug slows gastric emptying, meaning food stays in your stomach longer and you feel full for extended periods. It acts on brain regions that regulate appetite, reducing food cravings and the constant mental preoccupation with eating that sabotages many diets. It also improves insulin sensitivity and helps regulate blood sugar levels, which is why these medications were originally developed for type 2 diabetes.

The weight loss results from clinical trials are substantial and well-documented. In the STEP 1 trial, adults taking Semaglutide 2.4 mg weekly lost an average of 14.9% of their body weight over 68 weeks — that's about 33 pounds for a 220-pound man. The SURMOUNT-1 trial showed even more impressive results with Tirzepatide, with participants losing up to 20.9% of their body weight at the highest dose.

What makes these results particularly relevant for men struggling with weight is that they occur regardless of testosterone levels. You don't need a hormone deficiency to benefit from GLP-1 therapy. The medication works by addressing the fundamental challenge of sustainable weight loss: controlling hunger and reducing caloric intake in a way that doesn't require constant willpower.

In our clinical experience, men often respond very well to GLP-1 medications because they tend to have higher baseline caloric intakes. When the medication reduces appetite, the resulting calorie deficit can be significant. A man who was consuming 3,000 calories daily might naturally drop to 1,800-2,000 calories without feeling deprived or hungry — that deficit adds up quickly.

The Critical Difference: Treating a Deficiency vs Treating the Root Cause

This is where many men get confused, and frankly, where a lot of misleading marketing muddies the waters. Testosterone therapy treats a hormone deficiency. GLP-1 medications treat the metabolic and neurological factors that make weight loss difficult.

Think of it this way: if your car won't start because the battery is dead, replacing the battery fixes the problem. But if your car won't start because you're out of gas, a new battery won't help. Low testosterone is like a dead battery — if you have it, replacement therapy addresses the specific deficiency. But most men struggling with weight gain don't have clinically low testosterone. They have dysregulated appetite systems, insulin resistance, and metabolic adaptation from years of yo-yo dieting.

A 2020 study in the Journal of Clinical Endocrinology & Metabolism looked at obese men with normal testosterone levels who were randomized to receive either testosterone therapy or placebo while participating in a lifestyle modification program. After 56 weeks, there was no significant difference in weight loss between the groups. The men with normal testosterone who received TRT didn't lose more weight than those who didn't.

This finding is particularly important because testosterone levels naturally decline slightly with age and obesity. Some men assume this age-related decline is causing their weight gain, but research shows the opposite is more often true: obesity causes testosterone levels to drop through increased aromatase activity (which converts testosterone to estrogen in fat tissue) and inflammation affecting the hypothalamic-pituitary-gonadal axis. When these men lose weight through any method — including GLP-1 medications — their testosterone levels often normalize without any hormone replacement.

On the flip side, GLP-1 medications don't require any specific hormone profile to be effective. They work whether your testosterone is 250 ng/dL or 750 ng/dL. They address appetite and metabolism directly, which is why the weight loss results are so consistent across different patient populations.

Safety Considerations and Side Effects

Both therapies come with side effect profiles that men should understand before starting treatment. Testosterone replacement, when used appropriately in men with diagnosed hypogonadism, is generally safe under medical supervision. However, it carries risks including increased red blood cell production (which can thicken blood and increase clot risk), potential worsening of sleep apnea, acne, breast enlargement, testicular shrinkage, and reduced fertility. There's also ongoing debate about cardiovascular risks, though recent large studies have been somewhat reassuring for men with diagnosed hypogonadism.

Perhaps more concerning is what happens when testosterone is used inappropriately. Men with normal testosterone who take TRT will suppress their body's natural production. When they eventually stop, they may experience a prolonged period of genuinely low testosterone while their natural production recovers — if it fully recovers at all. We've seen patients who feel worse after discontinuing unnecessary TRT than they did before starting it.

GLP-1 medications have a different side effect profile. The most common issues are gastrointestinal: nausea, occasional vomiting, diarrhea, and constipation. These effects are usually mild to moderate and typically improve after the first few weeks as your body adjusts. Starting at a low dose and titrating up slowly minimizes these symptoms considerably. Less common but notable side effects include potential gallbladder issues and, very rarely, pancreatitis.

The key difference for men considering these options: GLP-1 medications don't interfere with your natural hormone production. When you stop taking them, there's no rebound effect or suppression to recover from. Your appetite regulation may gradually return to baseline, but you haven't altered your endocrine system in the process.

What Men Should Know

If you're a man considering either of these therapies for weight loss, start with honest answers to a few questions. First, do you have symptoms of genuine testosterone deficiency beyond just weight gain? We're talking about significantly reduced libido, erectile dysfunction, crushing fatigue that isn't explained by poor sleep or stress, and difficulty building or maintaining muscle even with resistance training. If so, get proper testing — and that means multiple early-morning testosterone measurements, not just a single test.

Second, understand that even if your testosterone is slightly below the reference range, that might be a consequence of excess weight rather than the cause. Many men see their testosterone levels rise naturally after losing weight through diet, exercise, or GLP-1 therapy. Starting TRT might lock you into lifelong therapy when weight loss alone could have resolved the issue.

Third, be realistic about what you're hoping to achieve. If your primary goal is significant weight loss — say, 30-50 pounds or more — GLP-1 medications have far stronger evidence supporting that outcome. Testosterone therapy, even in men with true hypogonadism, produces modest weight changes. It can help with muscle building and may slightly reduce body fat, but it's not primarily a weight loss intervention.

Finally, consider the long-term commitment. GLP-1 therapy is typically continued as long as you want to maintain the weight loss, though some people successfully transition to lower maintenance doses. Testosterone therapy, once started for true hypogonadism, is generally a lifelong commitment. Stopping and starting testosterone repeatedly can be problematic for your natural hormone production.

From the Ozari Care Team

We recommend thinking about these therapies as tools designed for different jobs. In our experience, most men who come to us primarily concerned about weight loss are better candidates for GLP-1 medications than testosterone therapy. What we tell our patients is this: get your testosterone checked properly first, but don't be disappointed if it's normal — that actually means you can lose weight effectively with GLP-1 therapy without the complications of hormone replacement. The men who see the best results are those who use these medications as part of a broader approach that includes sustainable eating patterns and regular activity, not as a standalone solution.

Key Takeaways

• Testosterone therapy is appropriate for men with clinically diagnosed low testosterone (under 300 ng/dL on multiple tests), but produces only modest weight loss of 4-7 pounds on average, even in men with true deficiency
• GLP-1 medications like Semaglutide and Tirzepatide produce substantial weight loss (15-21% of body weight) regardless of testosterone levels, making them more effective for men whose primary goal is significant weight reduction
• Obesity itself can lower testosterone levels, and losing weight through any method — including GLP-1 therapy — often normalizes testosterone without hormone replacement
• Testosterone therapy carries risks including suppression of natural hormone production, especially when used in men with normal levels, while GLP-1 medications don't interfere with hormone production
• Most men struggling with weight gain have normal testosterone and are better candidates for GLP-1 therapy than TRT, though some men with genuine hypogonadism may benefit from both under careful medical supervision

Frequently Asked Questions

Can I take GLP-1 medications and testosterone therapy at the same time?

Yes, these medications can be used together if you have genuine testosterone deficiency and also want to lose weight. There's no direct interaction between GLP-1 medications and testosterone replacement. However, most men don't need both — if your primary concern is weight loss and your testosterone is in the normal range, you'll likely see better results from GLP-1 therapy alone. If you do have diagnosed hypogonadism and significant weight to lose, your doctor might recommend addressing the weight first with GLP-1 therapy, as losing weight often raises testosterone naturally and might reduce or eliminate the need for hormone replacement.

Will losing weight on GLP-1 medications increase my testosterone naturally?

Yes, for many men it does. Multiple studies have shown that significant weight loss increases testosterone levels in men who were obese. One study found that men who lost about 10% of their body weight saw their testosterone increase by roughly 100 ng/dL on average. This happens because excess body fat, particularly visceral fat, contains an enzyme called aromatase that converts testosterone to estrogen. When you lose fat, you reduce this conversion and also decrease inflammatory signals that suppress testosterone production. We've seen numerous patients whose testosterone went from borderline low to solidly normal after losing 30-50 pounds on GLP-1 therapy, without any hormone replacement.

How do I know if my weight gain is actually caused by low testosterone?

Honestly, it probably isn't — but you should test to be sure. True hypogonadism significant enough to cause weight gain comes with other notable symptoms: markedly reduced sex drive, erectile problems, severe fatigue, difficulty concentrating, and trouble building muscle even when you're strength training consistently. If you have these symptoms, get proper testing with at least two early-morning testosterone measurements. Levels below 300 ng/dL on multiple tests indicate hypogonadism. However, if your only symptom is weight gain and your testosterone comes back at 400-500 ng/dL, that's within normal range — your weight gain is more likely due to the same factors affecting millions of other men: increased caloric intake, decreased activity, metabolic adaptation, and age-related changes in appetite regulation.

Why did my testosterone levels come back low when I got tested at age 45?

This is one of the most common scenarios we see. Yes, testosterone does decline slightly with age — about 1-2% per year after age 30. But if you're carrying extra weight, that's probably having a bigger impact on your testosterone than your age. Obesity suppresses testosterone through multiple mechanisms, and the relationship is bidirectional: low testosterone can make it slightly harder to maintain muscle mass, which can contribute to weight gain, which further lowers testosterone. Before starting lifelong hormone replacement, consider whether losing weight might normalize your levels. Many men find that dropping 30-40 pounds brings their testosterone from the 250-350 range up into the 450-550 range without any medication.

Are the weight loss results from GLP-1 medications the same for men and women?

The results are broadly similar, though there are some differences in how men and women tend to respond. In the major clinical trials, both men and women lost substantial amounts of weight, though some analyses suggest men may lose slightly more on average — possibly because men often start with higher caloric intakes, so the appetite suppression creates a larger deficit. Men also tend to carry more visceral fat (the dangerous kind around organs), which appears to respond well to GLP-1 therapy. In our clinical experience, men are often surprised by how much the medication reduces their appetite and food focus, particularly in the evening hours when many men do most of their overeating. The bottom line is that these medications are highly effective for both men and women when used appropriately.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, shipped to your door. Our clinical team can help you determine whether GLP-1 therapy is right for your weight loss goals and health situation. Learn more at ozarihealth.com.